Cargando…
Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability
Atropine (AT) and oximes, alone or in combination, have been proven greatly valuable therapeutics in the treatment of organophosphates intoxications. An injectable mixture of AT and obidoxime (OB) was formulated for the administration by automatic self-injector. The aqueous single dose solution cont...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813366/ https://www.ncbi.nlm.nih.gov/pubmed/24250669 |
_version_ | 1782289096686698496 |
---|---|
author | Ettehadi, Hossein Ali Ghalandari, Rouhollah Shafaati, Alireza Foroutan, Seyed Mohsen |
author_facet | Ettehadi, Hossein Ali Ghalandari, Rouhollah Shafaati, Alireza Foroutan, Seyed Mohsen |
author_sort | Ettehadi, Hossein Ali |
collection | PubMed |
description | Atropine (AT) and oximes, alone or in combination, have been proven greatly valuable therapeutics in the treatment of organophosphates intoxications. An injectable mixture of AT and obidoxime (OB) was formulated for the administration by automatic self-injector. The aqueous single dose solution contained 275 mg obidoxime chloride and 2.5 mg atropine sulfate per 1 mL (220 mg and 2 mg per 0.8 effective dose, respectively). The final solution was sterilized by filtration through a 0.22 μm pore size filter. This more concentrated solution allowed to use a smaller size and lighter weight cartridge. Quality control tests, including assay of the two major compounds were performed separately, using reversed-phase HPLC methods. Besides, the stability test was carried out according to ICH guideline for the accelerated test. The obtained results showed that the proposed formulation is stable over a period of 2 years after preparation. |
format | Online Article Text |
id | pubmed-3813366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-38133662013-11-18 Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability Ettehadi, Hossein Ali Ghalandari, Rouhollah Shafaati, Alireza Foroutan, Seyed Mohsen Iran J Pharm Res Original Article Atropine (AT) and oximes, alone or in combination, have been proven greatly valuable therapeutics in the treatment of organophosphates intoxications. An injectable mixture of AT and obidoxime (OB) was formulated for the administration by automatic self-injector. The aqueous single dose solution contained 275 mg obidoxime chloride and 2.5 mg atropine sulfate per 1 mL (220 mg and 2 mg per 0.8 effective dose, respectively). The final solution was sterilized by filtration through a 0.22 μm pore size filter. This more concentrated solution allowed to use a smaller size and lighter weight cartridge. Quality control tests, including assay of the two major compounds were performed separately, using reversed-phase HPLC methods. Besides, the stability test was carried out according to ICH guideline for the accelerated test. The obtained results showed that the proposed formulation is stable over a period of 2 years after preparation. Shaheed Beheshti University of Medical Sciences 2013 /pmc/articles/PMC3813366/ /pubmed/24250669 Text en © 2013 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ettehadi, Hossein Ali Ghalandari, Rouhollah Shafaati, Alireza Foroutan, Seyed Mohsen Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability |
title | Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability |
title_full | Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability |
title_fullStr | Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability |
title_full_unstemmed | Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability |
title_short | Development of a Combined Solution Formulation of Atropine Sulfate and Obidoxime Chloride for Autoinjector and Evaluation of Its Stability |
title_sort | development of a combined solution formulation of atropine sulfate and obidoxime chloride for autoinjector and evaluation of its stability |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813366/ https://www.ncbi.nlm.nih.gov/pubmed/24250669 |
work_keys_str_mv | AT ettehadihosseinali developmentofacombinedsolutionformulationofatropinesulfateandobidoximechlorideforautoinjectorandevaluationofitsstability AT ghalandarirouhollah developmentofacombinedsolutionformulationofatropinesulfateandobidoximechlorideforautoinjectorandevaluationofitsstability AT shafaatialireza developmentofacombinedsolutionformulationofatropinesulfateandobidoximechlorideforautoinjectorandevaluationofitsstability AT foroutanseyedmohsen developmentofacombinedsolutionformulationofatropinesulfateandobidoximechlorideforautoinjectorandevaluationofitsstability |